​​​​Aging-US: Pineal gland associated with rapid eye movement sleep behavior disorder

09-08-2021

Aging-US published a Special Collection on Eye Disease which included "Pineal gland volume is associated with prevalent and incident isolated rapid eye movement sleep behavior disorder" which reported that pineal gland volume may be associated with the risk of isolated rapid eye movement (REM) sleep behavior disorder (RBD).

The authors enrolled 245 cognitively normal elderly individuals without major psychiatric or neurological disorders at the baseline evaluation and 2-year follow-up evaluation. The smaller the baseline pineal glands volume, the more severe the RBD symptoms at baseline. The individuals with isolated rBD showed smaller pineal gland volumes than those without isolated pRBD.

Dr. Ki Woong Kim from The Seoul National University College of Natural Sciences, The Seoul National University Bundang Hospital as well as The Seoul National University College of Medicine said, "Rapid eye movement (REM) sleep behavior disorder (RBD) is a parasomnia characterized by the loss of normal skeletal muscle atonia during REM sleep and dream-enacting behaviors."

"Rapid eye movement (REM) sleep behavior disorder (RBD) is a parasomnia characterized by the loss of normal skeletal muscle atonia during REM sleep and dream-enacting behaviors."

RBD can occur in association with (secondary RBD), or without (isolated RBD) a neurodegenerative disorder such as Parkinson's disease or Lewy body disease. A series of clinical trials found that the symptoms of RBD were improved by N-acetyl-5-methoxytryptamine (melatonin).

In RBD patients, dream-enacting behaviors were reduced and REM sleep muscle atonia were restored by the administration of melatonin. Melatonin is a multifunctioning indoleamine produced by the pineal gland, which regulates sleep and circadian rhythm through its production and synthesis. VPG may predict the risk of developing RBD; they investigated the association of VPG with current RBD symptoms cross-sectionally and with the future risk prospectively in cognitively normal individuals without neurological or psychiatric disorders.

Figure 2. (A) Diagnostic accuracy for prevalent probable REM sleep behavior disorder (pRBD) at the baseline evaluation and (B) predictive accuracy for incident pRBD at the 2-year follow-up evaluation of the baseline pineal parenchyma volume (VPP, mm3) and pineal gland volume (VPG, mm3). Abbreviations: AUC = area under the receiver operator characteristic curve; CI = confidence intervals.

The Kim Research Team concluded in their Aging-US Research Output, "the smaller pineal gland was associated with the more current RBD symptoms and the higher future risk of RBD in cognitively normal elderly individuals, and VPP or VPG may be a candidate biomarker of RBD."

Full Text - https://www.aging-us.com/article/102661/text

Correspondence to: Ki Woong Kim email: kwkimmd@snu.ac.kr

Keywords: pineal gland, RBD, MRI, aging, prospective

About Aging-US:

Aging publishes research papers in all fields of aging research including but not limited, aging from yeast to mammals, cellular senescence, age-related diseases such as cancer and Alzheimer’s diseases and their prevention and treatment, anti-aging strategies and drug development and especially the role of signal transduction pathways such as mTOR in aging and potential approaches to modulate these signaling pathways to extend lifespan. The journal aims to promote treatment of age-related diseases by slowing down aging, validation of anti-aging drugs by treating age-related diseases, prevention of cancer by inhibiting aging. Cancer and COVID-19 are age-related diseases.

Aging is indexed by PubMed/Medline (abbreviated as “Aging (Albany NY)”), PubMed CentralWeb of Science: Science Citation Index Expanded (abbreviated as “Aging‐US” and listed in the Cell Biology and Geriatrics & Gerontology categories), Scopus (abbreviated as “Aging” and listed in the Cell Biology and Aging categories), Biological Abstracts, BIOSIS Previews, EMBASE, META (Chan Zuckerberg Initiative) (2018-2022), and Dimensions (Digital Science).

Please visit our website at www.Aging-US.com and connect with us:

For media inquiries, please contact media@impactjournals.com.